Developer docs
API playgroundTry for free, no card

Search company profiles

Aalto Helsinki

Full company profile

uuid002m7od

Namestring
Aalto Helsinki
Legal namestring
Aalto-Helsinki
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Aalto-Helsinki is a student-driven synthetic biology competition team jointly operated by students from Aalto University (Espoo) and the University of Helsinki (Helsinki, Finland), founded in 2014 as the first Finnish team to participate in the international iGEM (International Genetically Engineered Machine) competition. The team fields a multidisciplinary roster of approximately 9-14 students per annual cycle spanning biology, biotechnology, bioinformatics, mathematics, chemistry, programming, design, and engineering, and operates sub-teams covering wet-lab, dry-lab, fundraising, collaboration, programming, writing, human practices, graphic design, social media, and video.

The team's core technology stack is synthetic biology and genetic engineering using standardized BioBrick parts, with project-specific applications including protein engineering, ribosome display, DARPin design, quorum-sensing biosensors, antimicrobial peptide production in E. coli, and computational modeling. Notable historical and ongoing projects include: a 2014 remote-controlled bacterial gene expression system; 2015 propane production; 2016 cyanotoxin detection and degradation via engineered yeast; 2017 dermcidin-derived (DCD-1L) antimicrobial peptides for acne in E. coli; 2018 microbial natural dyes combined with spider silk proteins; the 2022 QBlock project using DARPins to bind AIP molecules and prevent biofilm formation in chronic wounds (which won a Gold Medal at the Grand Jamboree in Paris); 2023 PET upcycling into single-cell proteins; and the 2026 fusion protein-based histamine test-strip biosensor for home-use detection by histamine-intolerant individuals. The team operates under academic mentorship with laboratory access at Aalto University, the University of Helsinki, HiLife (Helsinki Institute of Life Science), and VTT Technical Research Centre of Finland.

Aalto-Helsinki does not operate a commercial business. There are no products or services sold, no pricing model, and no commercial revenue stream. The entity is funded through university institutional support, in-kind laboratory sponsorship (notably from Thermo Fisher Scientific, IDT, BioNordika, Geneious), and financial sponsorship (Kemianteollisuus, TEK, ERASynBio, Loimu). All projects are academic proof-of-concept research, not commercial products; the Gold Medal at the 2022 Grand Jamboree represents the team's primary measurable competitive credential. Outreach activities include a podcast on Spotify, blog, Instagram, LinkedIn, science workshops at Heureka, and public presentations at Science Basement.

Short descriptiontext

Aalto-Helsinki is a student-driven synthetic biology research team from Aalto University and University of Helsinki, participating in the iGEM competition since 2014 as Finland's first entrant. The team develops annual proof-of-concept biotech projects addressing healthcare, environmental, and sustainability challenges through genetic engineering and molecular biology, with no commercial revenue.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHelsinki, Finland
HQ citystring
Helsinki
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
synthetic biology research, biosensor development, protein engineering, biotechnology competition, genetic engineering
Industry4 codes
1“Free-From” & Allergen-Free Claim Substantiation (e.g., gluten-free, peanut-free)
CodeAFALAHADPrimaryYes
2Labeling, Nutrition Facts & Allergen Verification Services
CodeAFALAAAHPrimaryNo
3Food Testing Laboratories (Microbiological, Chemical, Allergen)
CodeAFALAAAAPrimaryNo
4Method Development & Validation (ICH/USP)
CodeHLAGADABPrimaryNo
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
  • Laboratory Analytical Instruments3826
Product category
Synthetic Biology Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Competition funding and sponsorships
TypeProfessional Services
Description

Student team funded through university support, private sponsors, and competition grants. No commercial revenue generation.

aaltohelsinki.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Aalto Helsinki is a student-driven synthetic biology research team that produces annual proof-of-concept biotechnology projects for the international iGEM competition. The team combines biology, biotechnology, bioinformatics, chemistry, mathematics, programming, design, and engineering expertise to develop synthetic biology solutions addressing healthcare, environmental, and sustainability challenges. Their current 2026 offering is a fusion protein-based histamine test-strip biosensor for home-use detection of histamine in food by people with histamine intolerance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Gold Medal achievement at 2022 Grand Jamboree
+1 more record
Product overview1 text field

Aalto Helsinki is a student-driven research team participating in the iGEM (International Genetically Engineered Machine) synthetic biology competition. The team comprises students from Aalto University and University of Helsinki working on annual biotechnology research projects. Their 2026 project focuses on developing a fusion protein-based histamine test-strip biosensor for home-use by people with histamine intolerance. Historical projects have included PET upcycling (2023), QBlock for chronic wound treatment (2022), dermcidin-based acne treatment (2017), natural dye production with spider silk proteins (2018), cyanotoxin detection from blue-green algae (2016), propane production (2015), and remote-controlled bacterial gene expression (2014). These are academic research projects, not commercial products.

Product and service1 record
1Biosensor for Histamine Detection (iGEM 2026 project)
CategorySynthetic biology research project / biosensor proof-of-concept
Description

A fusion protein-based home-use histamine test-strip biosensor targeting people with histamine intolerance (approximately 1% of the global population). The strip combines a diamine oxidase (DAO) domain for histamine degradation, a color-changing enzyme that responds to hydrogen peroxide, and a cellulose-binding protein to anchor the complex onto the test strip. Designed for everyday consumer use to detect histamine in foods such as cheese, wine, fermented foods, spinach, and seafood.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierMajorTypeTechnology or IntegrationAnnounced on2022-01-01
Description

Collaboration to test BioXp DNA, mRNA, and protein synthesizing machine. Received opportunity to synthesize DARPin DNA fragments for the 2022 project.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2022-01-01
Description

Finnish distributor for Codex DNA products, facilitated BioXp machine access and provided technical support.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Main research collaborator on dry-lab side for computational modeling of DARPin passage through biofilm matrix. Both teams focus on chronic wound healing.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Only other Finnish iGEM team collaboration for workshops at Heureka, Science Basement presentations, and bioethics discussions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Helsinki Institute of Life Science provides institutional support and laboratory facilities. Logo displayed on partner section of website.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Faculty of Science, Department of Food Sciences, and other departments provide academic support and resources.

Strategic tierMajorTypeTechnology or Integration
Description

Provides laboratory equipment and reagents sponsorship. Logo displayed on partner section.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Finnish Science Center collaborator for educational workshops and outreach programs, particularly for children.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research institution providing laboratory space and scientific expertise.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Home university providing primary institutional support, laboratory space, and mentorship from professors and staff.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner university providing academic support and research facilities.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Aalto University startup society providing entrepreneurial support and connections.

Strategic tierMajorTypeTechnology or Integration
Description

DNA synthesis and reagents provider, long-term sponsor.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Industrial synthetic biology company developing engineered enzymes for pharmaceutical manufacturing and sustainable chemistry. Comparable as a commercial-scale application of protein engineering and enzyme design concepts that iGEM teams like Aalto-Helsinki explore academically through DARPin and fusion protein work.

TypeBroad incumbent
Description

Founded by former iGEM participants, Ginkgo is the largest publicly-traded synthetic biology platform company. Comparable as the commercial maturation of iGEM-style synthetic biology into industrial-scale cell engineering, though operating at vastly larger scale with full equity and revenue structure.

TypeOthers
Description

Major life sciences tools provider and equipment sponsor for Aalto-Helsinki. Comparable as the dominant infrastructure provider whose reagents, instruments, and laboratory equipment underpin synthetic biology research across academia and industry.

TypeBroad incumbent
Description

Synthetic biology company producing sustainable ingredients via engineered microbes. Comparable as a commercial-stage example of microbial strain engineering for sustainable consumer products, paralleling Aalto-Helsinki's natural dye production and PET upcycling projects at industrial scale.

TypeBroad incumbent
Description

Commercial DNA synthesis platform serving synthetic biology researchers globally. Comparable as commercial infrastructure for synthetic biology, with which Aalto-Helsinki's projects (DNA assembly, BioBrick parts, biosensor engineering) directly interact and depend upon.

TypeOthers
Description

DNA synthesis and reagents provider that is a long-term sponsor of Aalto-Helsinki. Comparable as a key enabling technology partner whose oligonucleotide products and DNA synthesis services directly underpin the team's synthetic biology research workflows.

TypeOthers
Description

Synthetic biology tools company providing the BioXp DNA/mRNA/protein synthesis machine used by Aalto-Helsinki for their 2022 DARPin project. Directly comparable as a technology partner enabling rapid DNA-to-protein workflows central to synthetic biology prototyping.

TypeDirect peer
Description

The only other Finnish iGEM team, with whom Aalto-Helsinki collaborates on workshops at Heureka science center, joint bioethics discussions, and Science Basement presentations. Both are student-driven synthetic biology competition teams operating in the same Finnish geographic market with similar academic structures.

TypeDirect peer
Description

Historically the most successful iGEM team globally, originating the competition itself and producing multiple gold medal winners and category winners. Directly comparable as a leading student-driven synthetic biology team with elite institutional backing, multidisciplinary structure, and consistent gold medal track record.

TypeOthers
Description

Finnish research institution providing laboratory space, equipment, and scientific expertise to Aalto-Helsinki. Comparable as a domestic applied research partner bridging academic synthetic biology to industrial applications within the Finnish bioeconomy.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aalto Helsinki

Synthetic Biology Researchaaltohelsinki.com

Aalto-Helsinki is a student-driven synthetic biology research team from Aalto University and University of Helsinki, participating in the iGEM competition since 2014 as Finland's first entrant. The team develops annual proof-of-concept biotech projects addressing healthcare, environmental, and sustainability challenges through genetic engineering and molecular biology, with no commercial revenue.

What Aalto Helsinki does

Aalto-Helsinki is a student-driven synthetic biology competition team jointly operated by students from Aalto University (Espoo) and the University of Helsinki (Helsinki, Finland), founded in 2014 as the first Finnish team to participate in the international iGEM (International Genetically Engineered Machine) competition. The team fields a multidisciplinary roster of approximately 9-14 students per annual cycle spanning biology, biotechnology, bioinformatics, mathematics, chemistry, programming, design, and engineering, and operates sub-teams covering wet-lab, dry-lab, fundraising, collaboration, programming, writing, human practices, graphic design, social media, and video.

The team's core technology stack is synthetic biology and genetic engineering using standardized BioBrick parts, with project-specific applications including protein engineering, ribosome display, DARPin design, quorum-sensing biosensors, antimicrobial peptide production in E. coli, and computational modeling. Notable historical and ongoing projects include: a 2014 remote-controlled bacterial gene expression system; 2015 propane production; 2016 cyanotoxin detection and degradation via engineered yeast; 2017 dermcidin-derived (DCD-1L) antimicrobial peptides for acne in E. coli; 2018 microbial natural dyes combined with spider silk proteins; the 2022 QBlock project using DARPins to bind AIP molecules and prevent biofilm formation in chronic wounds (which won a Gold Medal at the Grand Jamboree in Paris); 2023 PET upcycling into single-cell proteins; and the 2026 fusion protein-based histamine test-strip biosensor for home-use detection by histamine-intolerant individuals. The team operates under academic mentorship with laboratory access at Aalto University, the University of Helsinki, HiLife (Helsinki Institute of Life Science), and VTT Technical Research Centre of Finland.

Aalto-Helsinki does not operate a commercial business. There are no products or services sold, no pricing model, and no commercial revenue stream. The entity is funded through university institutional support, in-kind laboratory sponsorship (notably from Thermo Fisher Scientific, IDT, BioNordika, Geneious), and financial sponsorship (Kemianteollisuus, TEK, ERASynBio, Loimu). All projects are academic proof-of-concept research, not commercial products; the Gold Medal at the 2022 Grand Jamboree represents the team's primary measurable competitive credential. Outreach activities include a podcast on Spotify, blog, Instagram, LinkedIn, science workshops at Heureka, and public presentations at Science Basement.

Aalto Helsinki firmographics

Firmographics
Name
Aalto Helsinki
Legal name
Aalto-Helsinki
Website
https://aaltohelsinki.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Aalto-Helsinki is a student-driven synthetic biology research team from Aalto University and University of Helsinki, participating in the iGEM competition since 2014 as Finland's first entrant. The team develops annual proof-of-concept biotech projects addressing healthcare, environmental, and sustainability challenges through genetic engineering and molecular biology, with no commercial revenue.
Ownership category
akta.pro rank

Aalto Helsinki industry classification

Industry
Product category
Synthetic Biology Research
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Laboratory Analytical Instruments (3826)
akta.pro primary industry
“Free-From” & Allergen-Free Claim Substantiation (e.g., gluten-free, peanut-free) (AFALAHAD)
akta.pro secondary industries
Labeling, Nutrition Facts & Allergen Verification Services (AFALAAAH), Food Testing Laboratories (Microbiological, Chemical, Allergen) (AFALAAAA), Method Development & Validation (ICH/USP) (HLAGADAB)

Keywords

  • Synthetic biology research
  • Biosensor development
  • Protein engineering
  • Biotechnology competition
  • Genetic engineering

Where Aalto Helsinki is headquartered

Location

Headquarters

HQ city
Helsinki
HQ country
Finland
HQ region
Europe

Offices2 records

Markets served

Aalto Helsinki business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Competition funding and sponsorships: Student team funded through university support, private sponsors, and competition grants. No commercial revenue generation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Aalto Helsinki product offering

Product offering

Core offering

Aalto Helsinki is a student-driven synthetic biology research team that produces annual proof-of-concept biotechnology projects for the international iGEM competition. The team combines biology, biotechnology, bioinformatics, chemistry, mathematics, programming, design, and engineering expertise to develop synthetic biology solutions addressing healthcare, environmental, and sustainability challenges. Their current 2026 offering is a fusion protein-based histamine test-strip biosensor for home-use detection of histamine in food by people with histamine intolerance.

Product overview

Aalto Helsinki is a student-driven research team participating in the iGEM (International Genetically Engineered Machine) synthetic biology competition. The team comprises students from Aalto University and University of Helsinki working on annual biotechnology research projects. Their 2026 project focuses on developing a fusion protein-based histamine test-strip biosensor for home-use by people with histamine intolerance. Historical projects have included PET upcycling (2023), QBlock for chronic wound treatment (2022), dermcidin-based acne treatment (2017), natural dye production with spider silk proteins (2018), cyanotoxin detection from blue-green algae (2016), propane production (2015), and remote-controlled bacterial gene expression (2014). These are academic research projects, not commercial products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biosensor for Histamine Detection (iGEM 2026 project) A fusion protein-based home-use histamine test-strip biosensor targeting people with histamine intolerance (approximately 1% of the global population). The strip combines a diamine oxidase (DAO) domain for histamine degradation, a color-changing enzyme that responds to hydrogen peroxide, and a cellulose-binding protein to anchor the complex onto the test strip. Designed for everyday consumer use to detect histamine in foods such as cheese, wine, fermented foods, spinach, and seafood.

Quantifiable outcome

  • Gold Medal achievement at 2022 Grand Jamboree
  • +1 more outcomes

Companies that use Aalto Helsinki

Customer profile

Segments5 records

Ideal customer profiles2 records

Aalto Helsinki technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Aalto Helsinki partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered major, minor and core.

  • Codex DNAmajorTechnology or Integration · 1 January 2022Collaboration to test BioXp DNA, mRNA, and protein synthesizing machine. Received opportunity to synthesize DARPin DNA fragments for the 2022 project.
  • Immuno Diagnostics OymajorTechnology or Integration · 1 January 2022Finnish distributor for Codex DNA products, facilitated BioXp machine access and provided technical support.
  • TU DresdenmajorStrategic or Co-development Partner · 1 January 2022Main research collaborator on dry-lab side for computational modeling of DARPin passage through biofilm matrix. Both teams focus on chronic wound healing.
  • Aboa (Turku) iGEM TeamminorStrategic or Co-development Partner · 1 January 2022Only other Finnish iGEM team collaboration for workshops at Heureka, Science Basement presentations, and bioethics discussions.
  • HiLife (Helsinki Institute of Life Science)coreStrategic or Co-development PartnerHelsinki Institute of Life Science provides institutional support and laboratory facilities. Logo displayed on partner section of website.
  • University of Helsinki DepartmentscoreStrategic or Co-development PartnerFaculty of Science, Department of Food Sciences, and other departments provide academic support and resources.
  • Thermo Fisher ScientificmajorTechnology or IntegrationProvides laboratory equipment and reagents sponsorship. Logo displayed on partner section.
  • HeurekamajorStrategic or Co-development PartnerFinnish Science Center collaborator for educational workshops and outreach programs, particularly for children.
  • VTT Technical Research Centre of FinlandcoreStrategic or Co-development PartnerResearch institution providing laboratory space and scientific expertise.
  • Aalto UniversitycoreStrategic or Co-development PartnerHome university providing primary institutional support, laboratory space, and mentorship from professors and staff.
  • University of HelsinkicoreStrategic or Co-development PartnerPartner university providing academic support and research facilities.
  • AaltoESminorGTM or Marketing PartnerAalto University startup society providing entrepreneurial support and connections.
  • IDT (Integrated DNA Technologies)majorTechnology or IntegrationDNA synthesis and reagents provider, long-term sponsor.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Aalto Helsinki competitors and assessment

Company assessment

Broad incumbents

  • Codexis: Industrial synthetic biology company developing engineered enzymes for pharmaceutical manufacturing and sustainable chemistry. Comparable as a commercial-scale application of protein engineering and enzyme design concepts that iGEM teams like Aalto-Helsinki explore academically through DARPin and fusion protein work.
  • Ginkgo Bioworks: Founded by former iGEM participants, Ginkgo is the largest publicly-traded synthetic biology platform company. Comparable as the commercial maturation of iGEM-style synthetic biology into industrial-scale cell engineering, though operating at vastly larger scale with full equity and revenue structure.
  • Amyris: Synthetic biology company producing sustainable ingredients via engineered microbes. Comparable as a commercial-stage example of microbial strain engineering for sustainable consumer products, paralleling Aalto-Helsinki's natural dye production and PET upcycling projects at industrial scale.
  • Twist Bioscience: Commercial DNA synthesis platform serving synthetic biology researchers globally. Comparable as commercial infrastructure for synthetic biology, with which Aalto-Helsinki's projects (DNA assembly, BioBrick parts, biosensor engineering) directly interact and depend upon.

Others

  • Thermo Fisher Scientific: Major life sciences tools provider and equipment sponsor for Aalto-Helsinki. Comparable as the dominant infrastructure provider whose reagents, instruments, and laboratory equipment underpin synthetic biology research across academia and industry.
  • Integrated DNA Technologies (IDT): DNA synthesis and reagents provider that is a long-term sponsor of Aalto-Helsinki. Comparable as a key enabling technology partner whose oligonucleotide products and DNA synthesis services directly underpin the team's synthetic biology research workflows.
  • Codex DNA: Synthetic biology tools company providing the BioXp DNA/mRNA/protein synthesis machine used by Aalto-Helsinki for their 2022 DARPin project. Directly comparable as a technology partner enabling rapid DNA-to-protein workflows central to synthetic biology prototyping.
  • VTT Technical Research Centre of Finland: Finnish research institution providing laboratory space, equipment, and scientific expertise to Aalto-Helsinki. Comparable as a domestic applied research partner bridging academic synthetic biology to industrial applications within the Finnish bioeconomy.

Direct peers

  • Aboa (Turku) iGEM Team: The only other Finnish iGEM team, with whom Aalto-Helsinki collaborates on workshops at Heureka science center, joint bioethics discussions, and Science Basement presentations. Both are student-driven synthetic biology competition teams operating in the same Finnish geographic market with similar academic structures.
  • MIT iGEM Team: Historically the most successful iGEM team globally, originating the competition itself and producing multiple gold medal winners and category winners. Directly comparable as a leading student-driven synthetic biology team with elite institutional backing, multidisciplinary structure, and consistent gold medal track record.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Aalto Helsinki social profiles

Digital presence

Aalto Helsinki financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aalto Helsinki leadership team

Management profile

Number of profiles

Profiles3 records

Aalto Helsinki funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aalto Helsinki M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aalto Helsinki

What does Aalto Helsinki do?

Aalto Helsinki is a student-driven synthetic biology research team that produces annual proof-of-concept biotechnology projects for the international iGEM competition. The team combines biology, biotechnology, bioinformatics, chemistry, mathematics, programming, design, and engineering expertise to develop synthetic biology solutions addressing healthcare, environmental, and sustainability challenges. Their current 2026 offering is a fusion protein-based histamine test-strip biosensor for home-use detection of histamine in food by people with histamine intolerance.

Is Aalto Helsinki a public or private company?

Aalto Helsinki is a private company. It is classified as unknown and is currently operating.

When was Aalto Helsinki founded?

Aalto Helsinki was founded in 2014. It employs 1 to 10 people.

Where is Aalto Helsinki based?

Aalto Helsinki is headquartered in Helsinki, Finland, in the Europe region.

How does Aalto Helsinki make money?

One revenue line is on record: competition funding and sponsorships.

Who are Aalto Helsinki's main competitors?

Broad incumbents on record are Codexis, Ginkgo Bioworks, Amyris and Twist Bioscience. Others are Thermo Fisher Scientific, Integrated DNA Technologies (IDT), Codex DNA and VTT Technical Research Centre of Finland. Direct peers are Aboa (Turku) iGEM Team and MIT iGEM Team.

Does Aalto Helsinki have an API?

No public API is recorded for Aalto Helsinki.

What industry is Aalto Helsinki in?

Aalto Helsinki's product category is Synthetic Biology Research. Its primary akta.pro industry code is AFALAHAD, “Free-From” & Allergen-Free Claim Substantiation (e.g., gluten-free, peanut-free), with a secondary code of AFALAAAH, Labeling, Nutrition Facts & Allergen Verification Services. Its NAICS code is 334516 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales